Amanote Research
Register
Sign In
HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: A Desirable Vaccine Component
Journal of Virology
- United States
doi 10.1128/jvi.07164-11
Full Text
Open PDF
Abstract
Available in
full text
Categories
Insect Science
Immunology
Microbiology
Virology
Date
May 2, 2012
Authors
L. Yang
Y. Song
X. Li
X. Huang
J. Liu
H. Ding
P. Zhu
P. Zhou
Publisher
American Society for Microbiology
Related search
Varied Properties of Hepatitis-Delta Virus-Like Particles Produced by Baculovirus-Transduced Mammalian Cells
Open Biotechnology Journal
Biochemistry
Biotechnology
Biophysics
Biomedical Engineering
Bioengineering
Vaccine Potential of Nipah Virus-Like Particles
PLoS ONE
Multidisciplinary
COL1A1Transgene Expression in Stably Transfected Osteoblastic Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Virus Like Particles as a Platform for Cancer Vaccine Development
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
P02-10. Plant Expression of Chimeric Gag/Gp41 Virus-Like Particles as a Mucosally-Targeted Subunit Vaccine Against HIV-1
Retrovirology
Virology
Infectious Diseases
Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells
APOBEC3G Is Incorporated Into Virus-Like Particles by a Direct Interaction With HIV-1 Gag Nucleocapsid Protein
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Virus-Like Particles and Nanoparticles for Vaccine Development Against HCMV
Viruses
Virology
Infectious Diseases
Structural Analysis of Influenza Vaccine Virus-Like Particles Reveals a Multicomponent Organization
Scientific Reports
Multidisciplinary